COVID-19: US Govt Gobbles Up 150 Million BinaxNOW Rapid Tests From Abbott
Executive Summary
Abbott will be paid $760m for the tests under a contract with the Department of Health and Human Services and the Department of Defense.
You may also be interested in...
US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
FDA Authorizes Abbott’s '$5, 15 Minute' COVID-19 Antigen Test
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?